Axithra

TLDR

Axithra is an imec spinoff from Ghent developing Raman-on-chip technology to measure drug concentrations in blood in real time, enabling point-of-care therapeutic drug monitoring.

Overview

Founded by Leander Van Neste and spun out of imec, Axithra is developing miniaturized Raman spectroscopy chips that can detect and quantify drug molecules in blood without requiring a laboratory. Therapeutic drug monitoring, the process of measuring drug levels in patients to optimize dosing, currently requires lab-based analysis with results taking hours or days. Axithra's technology could bring this to the point of care in minutes.

The application is relevant for oncology, transplant medicine, and critical care, where precise drug dosing is critical and current monitoring is infrequent due to cost and turnaround time constraints.

As an imec spinoff, Axithra has access to world-class semiconductor fabrication and photonics research capabilities that are essential for scaling chip-based medical diagnostics.

Key People

• Leander Van Neste - Founder

Connections

Part of the Belgian deep-tech and medtech cluster, with roots in imec's research programs.